Across TCGA pan-cancer cohorts, FAAP100 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated FAAP100 data layer compared with 5 for mutation status and 6 for mass-spec protein.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher FAAP100 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FAAP100 expression acts as an unfavorable survival marker, although some lineages such as SCLC and READ show a favorable association.
KIRC, ACC, and KICH are the cancer types where FAAP100 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.